Odey Asset Management Group’s AbbVie ABBV Stock Holding History

Odey Asset Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,500	Closed	-$2.02M	–	25
2022 Q4	$2.02M	Hold	12,500	–	–	0.61%	16
2022 Q3	$1.68M	Hold	12,500	–	–	5.8%	5
2022 Q2	$1.92M	Hold	12,500	–	–	1.74%	10
2022 Q1	$2.03M	Hold	12,500	–	–	0.61%	31
2021 Q4	$1.69M	Buy	+12,500	New	+$1.48M	0.5%	41

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Odey Asset Management Group's ABBV Position: Q1 2023 in Review

Odey Asset Management Group sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 12,500 shares — an estimated $2.02M sold.

Odey Asset Management Group first reported a position in ABBV in Q4 2021 and held it in 5 quarters. The position peaked at $2.03M in Q1 2022. 3,141 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Odey Asset Management Group reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
Odey Asset Management Group sold 12,500 AbbVie shares in Q1 2023, an estimated $2.02M.
Odey Asset Management Group first reported a position in AbbVie in Q4 2021 and held it in 5 quarters.
Odey Asset Management Group's AbbVie position peaked at $2.03M in Q1 2022.
3,141 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Odey Asset Management Group's 13F filing for Q1 2023, filed 15 May 2023.